Use of cannabinoids in the treatment of epilepsy

US12427160B2 · 09/30/2025

FIG. 1 · Sheet 1

Download patent PDF Write about this patent

The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet …

Full text

1 sections

Official name

Use of cannabinoids in the treatment of epilepsy

Publication number

US12427160B2

Inventor / creator

Geoffrey Guy

Assignee / owner

Jazz Pharmaceuticals Research Uk Limited

Filing

04/23/2025

Publication

09/30/2025

Expiry

04/23/2045

Status

ACTIVE

Open Google Patents →

No articles yet — metadata is still available from the registry.

Comments

0 replies · cite patents with ^

Join the discussion

Continue with Google

No comments yet.